Home Archive by category "PPE In The News" (Page 8)

Category: PPE In The News

NIH-funded study shows sound sleep supports immune function | NHLBI, NIH

Getting a consistent good night’s sleep supports normal production and programming of hematopoietic stem cells, a building block of the body’s innate immune system, according to a small National Institutes of Health-supported study in humans and mice. Sleep has long been linked to immune function, but researchers discovered that getting enough of it influenced the environment where monocytes – a type of white blood cell – form, develop, and get primed to support immune function.Continue…

Click here to continue!

$35 insulin caps for Medicare patients is not enough

The sky-high cost of insulin is causing adults in the U.S. with diabetes to ration their medication. According to the American Diabetes Association (ADA), people with Type 1 diabetes need about two-to-three vials per month, which could total up to $1,000 or more. For those working to make ends meet, paying up to $300 a vial is near impossible, pushing people to either take less insulin than normal or skip a dosage entirely—putting their livesContinue…

Click here to continue!

The Relationship between Physical Activity and Long COVID: A Cross-Sectional Study

The relationship between Long Covid (LC) symptoms and physical activity (PA) levels are unclear. In this cross-sectional study, we examined this association, and the advice that individuals with LC received on PA. Adults with LC were recruited via social media. The New Zealand physical activity questionnaire short form (NZPAQ-SF) was adapted to capture current and pre-COVID-19 PA levels and activities of daily living (ADLs). Participants reported how PA affected their symptoms, and what PA recommendationsContinue…

Click here to continue!

Why RSV, cold, and flu season is off to an early, brutal start – Vox

It’s not just you or your kids: Cold and flu season is off to a particularly nasty start across the United States.With the country stepping down from the pandemic footing of the past few years, the various viruses that cause coughs, runny noses, and sore throats are now on the rebound. Cases of influenza and respiratory syncytial virus (RSV), a common respiratory bug that can occasionally turn serious for infants and older adults, had beenContinue…

Click here to continue!

Political ideology linked with COVID health outcomes | News | Harvard T.H. Chan School of Public Health

Boston, MA – The higher the exposure to political conservatism, the higher the COVID-19 mortality rates and stress on hospital intensive care unit (ICU) capacity, according to a new study from Harvard T.H. Chan School of Public Health. Source: Political ideology linked with COVID health outcomes | News | Harvard T.H. Chan School of Public Health

Click here to continue!

Network for Community-Engaged Primary Care Research | Community Engagement Alliance

Network for Community-Engaged Primary Care Research (NCPCR) supports the CEAL mission by leveraging community-engaged research in primary care settings to address health inequities. The trusted voices of health care providers are enabled as they engage patients within their communities. In this role, primary care providers actively address misinformation and disinformation related to prevention and treatment of coronavirus disease 2019 (COVID-19) and its lingering effects and symptoms. Source: Network for Community-Engaged Primary Care Research | CommunityContinue…

Click here to continue!

COVID-19 Bivalent Vaccine Boosters Have Been Authorized for School Age Children | FDA

The FDA authorized bivalent formulations of the Moderna and Pfizer-BioNTech COVID-19 vaccines for use as a single booster dose at least two months after completing primary or booster vaccination.The Moderna COVID-19 Vaccine, Bivalent is authorized for use as single booster dose in individuals 6 years of age and older. The Pfizer-BioNTech COVID-19 Vaccine, Bivalent is authorized for use as a single booster dose in individuals 5 years of age and older. Source: COVID-19 Bivalent VaccineContinue…

Click here to continue!

Experimental Monoclonal Antibodies Show Promise Against Epstein-Barr Virus | NIH: National Institute of Allergy and Infectious Diseases

A panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting. Moreover, one of the experimental mAbs provided nearly complete protection against EBV infection and lymphoma when tested in mice. The results appear online today in the journal Immunity. Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, in collaboration withContinue…

Click here to continue!

Should covid-19 vaccines and drugs be “not for profit”? | The BMJ

Yes—Mohga Kamal-Yanni Inequality in access to medicines and vaccines has been prevalent in developing countries for decades. The HIV epidemic of the 1980s revealed massive faults in the global system of biomedical research—primarily a reliance on market incentives to dictate research and development (R&D) of pharmaceuticals through intellectual property rights. Millions of people died of AIDS, mainly in Africa, for lack of access to the highly priced medicines that could have saved their lives. AndContinue…

Click here to continue!

RSV: Scary season for parents of young children | Pediatric research

We knew this day would come. School is back in session, there’s a chill in the air and everywhere you go you hear the sounds of the season: sniffling, sneezing and coughing.After two years of a global pandemic of a respiratory virus, these sounds might feel extra spooky. If you’re a parent of a newborn, they are definitely scary. Especially with rates of respiratory syncytial virus, or RSV, on the rise.RSV is normally an unexceptionalContinue…

Click here to continue!